Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

EROAD Limited Director's Dealing 2020

Feb 5, 2020

66188_rns_2020-02-05_d9d9d44f-d401-40d1-af29-aea76f497c5c.pdf

Director's Dealing

Open in viewer

Opens in your device viewer

==> picture [76 x 22] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests

Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

To NZX Limited; and
Name of listed issuer: EROAD Limited
Date this disclosure made: 5 February2020
Date of last disclosure: 3 February2020
Director or senior managergiving disclosure
Full name(s): Michael Bruce Bushby
Name of listed issuer: EROAD Limited
Name of related body corporate (if applicable): Not applicable
Position held in listed issuer: Independent Director

Summary of acquisition or disposal of relevant interest (excluding specified derivatives)

Class of affected quoted financial products: Ordinary shares inEROAD Limited(ERD)
Nature of the affected relevant interest(s): Registered holder andbeneficial owner
For that relevant interest-
Number held in class before acquisition or disposal: 7,963
Number held in class after acquisition or disposal: 0
Current registered holder(s): Michael Bruce Bushby
Registered holder(s) once transfers are registered: Not applicable

==> picture [70 x 74] intentionally omitted <==

Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)

le)
Not applicable
Not applicable
The notional value of the derivative (if any) or the notional amount of underlying financialproducts(if any): Not applicable
A statement as to whether the derivative is cash settled orphysicallysettled: Not applicable
Maturitydate of the derivative(if any): Not applicable
Expirydate of the derivative(if any): Not applicable
Theprice specified in the terms of the derivative(if any): Not applicable
Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of the underlyingfinancial products: Not applicable
_For that derivative,- _Parties to the derivative:If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative:
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: Not applicable

Details of transactions giving rise to acquisition or disposal

Total number of transactions to which notice relates: 2 2
Details of transactions requiring disclosure-Date of transaction:Nature of transaction:Name of anyotherpartyorparties to the transaction(if known):The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value,describe the consideration:Number of financialproducts to which the transaction related:If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details—Whether relevant interests were acquired or disposed of duringa closedperiod:
Date of transaction: 4 February2020 5 February2020
Nature of transaction: On market sale of 5,472EROAD ordinaryshares On market sale of 2,491EROAD ordinaryshares
Name of anyotherpartyorparties to the transaction(if known): Unknown Unknown
The consideration, expressed in New Zealand dollars, paid or received for the acquisitionor disposal. If the consideration was not in cash and cannot be readily by converted into acash value,describe the consideration: $17,236.80 $7,846.65
Number of financialproducts to which the transaction related: 5,472 2,491
If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details— YesYes24-Jan-20
Whether relevant interests were acquired or disposed of duringa closedperiod: Yes
Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod: Yes
Date of the prior written clearance(if any): 24-Jan-20

Summary of other relevant interests after acquisition or disposal:

Summary of other relevant interests after acquisition or disposal:
Ordinary shares in
Class ofquoted financialproducts: EROAD Limited(ERD)
Michael Bushby is a
director of Lowelly Pty
Limited and accordingly
has the power to control
dealings and voting of
shares held by Lowelly
Pty Limited as trustee for
the Lowelly
Superannuation Fund.
Michael Bushby is also a
beneficiary of the Lowelly
Nature of relevant interest: Superannuation Fund.
_For that relevant interest,- _
Number held in class: 137,671
Current registered holder(s): LowellyPtyLimited
For a derivative relevant interest,-
Type of derivative: Not applicable
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying financial
products (if any): Not applicable
A statement as to whether the derivative is cash settled or physically settled: Not applicable
Maturity date of the derivative (if any): Not applicable
Expiry date of the derivative (if any): Not applicable
The price's specified terms (if any): Not applicable
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the underlying
financialproducts: Not applicable
For that derivative relevant interest,- Not applicable
Parties to the derivative: Not applicable
If the director or senior manager is not a party to the derivative, the nature of the relevant
interest in the derivative: Not applicable
Certification
I certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all persons
for whom it is made.
Signature of director or officer:
Date of signature: 5 February 2020
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorisedperson: